China Medical Device QMS
Adapting your medical device QMS (Quality Management System) to meet China’s regulatory requirements is challenging but essential to obtain market approval and ensure ongoing compliance.
The National Medical Products Administration (NMPA), which succeeded the China Food and Drug Administration, is the authority responsible for ensuring that devices and IVDs on the market are fully compliant. To strengthen oversight, the NMPA released the 58th Announcement on December 12th, 2014, focusing on the implementation of Good Supplier Practices (GSP) for medical device distributors. These regulatory requirements apply across the entire product lifecycle to safeguard patient health and product performance.
This means that IVD and Medical Device QMS as well as overall compliance will be checked at various stages throughout their lifecycle.
.avif)
Full Lifecycle QMS Checks
Understanding how these obligations translate into concrete checkpoints is critical, as compliance will be verified at multiple stages before and after market entry.
Quality Management System Requirements
The Quality Management System (QMS) is a cornerstone of medical device and IVD regulations. The NMPA mandates that medical device manufacturers establish and maintain a QMS that not only meets ISO 13485 standards but also incorporates specific Chinese quality management standards. This comprehensive system must cover the entire product lifecycle, from initial design and development to production, quality control, and post-market surveillance.
Medical device manufacturers are required to conduct regular audits and self-inspections to ensure adherence to quality management and identify areas for improvement. The QMS must include detailed procedures for risk management, adverse event reporting, and post-market surveillance, as well as stringent document control and record-keeping practices. By implementing a robust QMS, manufacturers can fully comply with China’s medtech and IVD regulations, maintain high standards of quality and safety, and ultimately protect patient health.
In summary, well-implemented quality management is not just a regulatory requirement but a critical component in the lifecycle of devices, ensuring they meet the highest standards of safety and effectiveness in the Chinese market.
Our Quality Management Systems Services
We provide end-to-end support to achieve compliance for your Quality Management Systems (QMS) and Good Manufacturing Practices (GMP) to ensure you meet all regulatory requirements.
QMS Gap Analysis & Adaptation
Document Preparation & Compliance Support
Supplier Qualification & Quality Control
Production Process Compliance
Chinese GMP Audits
Complying with China’s GMP requirements is mandatory, often requiring on-site audits by the NMPA. Our team helps domestic and overseas manufacturers prepare for and pass these audits with a structured and efficient approach.
GMP Audit Preparation & Mock Inspections
On-Site & Remote NMPA Inspection Support
GMP Documentation & Process Compliance
Corrective & Preventive Actions (CAPA) Implementation
If you would like more information on China's Medical Device Good Manufacturing Practices and our services please click here.
Explore Related Services
Whether you’re just starting out or are a blue-chip, access our wide range of services and solutions to help your business thrive.
China Medical Device Registration
We guide you through every step of the China medical device registration and filing process. We take care of compliance with NMPA requirements, advising you on the optimal market entry pathway, and helping you through the whole process.
NMPA Legal Agent
We are your authorized representative in China, and fulfill your registrations and filings as well as ensuring compliance with quality and PMS requirements.
China Clinical Trials
You may be required to provide supplementary clinical data on Chinese patients or conduct a full clinical trial in China.Our clinical research team will advise you, prepare the study protocol and assist setting up the clinical trial in China.
NMPA Clinical Evaluation Report
Clinical Evaluation Reports can avoid the need for a China clinical trial in some instances. Our experts can advise and prepare NMPA compliant CERs.
Drug Device Combination Products
We assist with the classification, registration, and compliance of combination products in China, whether drug or device led.
NMPA Type Testing
Our on-site test engineers coordinate and supervise type tests of your medical devices in NMPA-accredited laboratories.
Medical Device PMS & Vigilance
The NMPA is placing greater focus on Post-Market Surveillance (PMS) such as more in-market sampling inspections and regular standard changes.Our specialist PMS team means you stay up to date with the many aspects of compliance.
